Globus Medical (GMED) Tops Q3 EPS by 40c

Globus Medical (NYSE: GMED) reported Q3 EPS of $1.18, $0.40 better than the analyst estimate of $0.78. Revenue for the quarter came in at $769 million versus the consensus estimate of $734.56 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Nscale targets up to $3B in US IPO as soon as September - Bloomberg
• Is the global equity rally broadening? UBS weighs in
• Can Anthropic actually match or beat SpaceX’s IPO? Numbers say "Yes, but"